Literature DB >> 421217

Effects of cis-dichlorodiammineplatinum(II) on human colon carcinoma cells in vitro.

J P Bergerat, B Barlogie, B Drewinko.   

Abstract

The lethal effects of cis-dichlorodiammineplatinum(II) were investigated on an established human colon carcinoma cell line. cis-Dichlorodiammineplatinum(II) was one of the most efficient antineoplastic agents tested thus far on this human colon carcinoma cell line. Survival of exponentially growing cells exposed to increasing concentrations of the drug (both in medium or in Hanks' balanced salt solution) was of the threshold exponential type (Dq = 1.2 microgram/ml, 1 hr; Do = 3.5 microgram/ml, 1 hr). Stationary-phase cells were extremely sensitive to the drug, and the survival curve demonstrated a simple exponential pattern (Do = 3.9 microgram/ml, 1 hr). Long-term exposure to low concentrations of cis-dichlorodiammineplatinum induced a high degree of killing, with only 0.5% of the cells surviving after incubation for 24 hr with 2 microgram/ml. Cells were unable to recover from potentially lethal or sublethal damages induced by the drug.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 421217

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Sensitivity of rodent osteosarcoma clones to platinum-containing phosphonic acid complexes in vitro.

Authors:  T Klenner; P Valenzuela-Paz; B K Keppler; H R Scherf
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine.

Authors:  E K Rowinsky; M J Citardi; D A Noe; R C Donehower
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

3.  Activity of two platinum-linked phosphonic acids against autochthonous rat colorectal cancer as well as in two human colon-cancer cell lines.

Authors:  A Galeano; M R Berger; B K Keppler
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Response of murine erythroleukemia cells to cis- and trans-diamminedichloroplatinum (II).

Authors:  T S Vates; G L Brake; S K Majumdar; G L Ferguson
Journal:  In Vitro Cell Dev Biol       Date:  1986-06

5.  Assessment of action of cis-diamminodichloro-platinum II on HeLa cells by different methods detects time-dependence.

Authors:  A Belfield; A P Simmonds
Journal:  Br J Cancer       Date:  1982-12       Impact factor: 7.640

6.  The relationship between cisplatin sensitivity and drug uptake into mammalian cells in vitro.

Authors:  H Eichholtz-Wirth; B Hietel
Journal:  Br J Cancer       Date:  1986-08       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.